HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hilke Zander Selected Research

Activated-Leukocyte Cell Adhesion Molecule (Neurolin)

6/2014Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
9/2012Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
7/2012ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
4/2012Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
1/2012ALCAM (CD166) expression and serum levels in pancreatic cancer.
1/2012Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
10/2011ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hilke Zander Research Topics

Disease

12Neoplasms (Cancer)
11/2020 - 02/2011
3Carcinoma (Carcinomatosis)
11/2020 - 04/2012
3Neoplasm Metastasis (Metastasis)
09/2013 - 10/2011
3Carcinogenesis
09/2012 - 02/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2016 - 06/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2012 - 07/2011
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2011 - 02/2011
1Hodgkin Disease (Hodgkin's Disease)
11/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2020
1Melanoma (Melanoma, Malignant)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Esophageal Neoplasms (Esophageal Cancer)
07/2012
1Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2012
1Breast Neoplasms (Breast Cancer)
01/2012
1Chronic Pancreatitis
01/2012
1Primitive Neuroectodermal Tumors (PNET)
10/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2011
1Adenocarcinoma
08/2011
1Demyelinating Diseases (Demyelinating Disease)
08/2003
1Multiple Sclerosis
08/2003
1Chlamydia Infections
08/2003

Drug/Important Bio-Agent (IBA)

7Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
06/2014 - 10/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2020 - 10/2011
2Monoclonal AntibodiesIBA
11/2020 - 04/2012
2Chemokine ReceptorsIBA
09/2013 - 08/2011
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
04/2012 - 05/2011
2Proteins (Proteins, Gene)FDA Link
01/2012 - 08/2003
2Biomarkers (Surrogate Marker)IBA
01/2012 - 10/2011
2MidkineIBA
07/2011 - 02/2011
1Tumor Biomarkers (Tumor Markers)IBA
04/2016
1TenascinIBA
04/2016
1Chemokine CXCL12IBA
09/2013
1CXCR4 Receptors (CXCR4 Receptor)IBA
09/2013
1Complementary DNA (cDNA)IBA
01/2012
1Messenger RNA (mRNA)IBA
01/2012
1Hormones (Hormone)IBA
10/2011
1ChemokinesIBA
08/2011
1Imatinib Mesylate (Gleevec)FDA Link
02/2011
1Myelin-Oligodendrocyte GlycoproteinIBA
08/2003
1AutoantibodiesIBA
08/2003

Therapy/Procedure

5Therapeutics
11/2020 - 02/2011
1Radiotherapy
04/2012